Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Etretinate treatment changed hair growth patterns in many patients.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

A woman developed lupus after taking hydroxyurea for two years.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

A patient developed a blister at the injection site after hepatitis C treatment.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

The patient improved after antiviral treatment for a viral infection.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Ritlecitinib is safe and may effectively treat alopecia areata.